Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Works in Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Musculoskeletal · Oncology · Renal & urogenital · Respiratory · Women's health

Suzhou Zelgen Biopharmaceuticals Co.,Ltd is a clinical trial sponsor. It has 22 active clinical trials with 3,966 planned participants, across 12 therapeutic areas. Since 2021 it has completed 33 trials and stopped 9 early.

Trial track record · since 2021

22Active trials3,966 planned participants
33Completed0 with results posted
9Stopped early21% of finished trials

Pipeline · 22 active trials

StageTrialStatus

Questions about Suzhou Zelgen Biopharmaceuticals Co.,Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-03.

Approve Suite is not affiliated with Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.